Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Nektar Therapeutics AL, Corporation”

42 pharma patents match "Nektar Therapeutics AL, Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 42
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 42 pharmaceutical patents matching "Nektar Therapeutics AL, Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

42 results for “Nektar Therapeutics AL, Corporation” · 30,257 patents in full index Clear search

  1. US 7589157

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Sep 15, 2009 · Expires Sep 10, 2029

    granted

  2. US 7579444

    Polymer-factor IX moiety conjugates

    Nektar Therapeutics AL, Corporation · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted

  3. US 7569214

    Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid

    Nektar Therapeutics AL, Corporation · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  4. US 7547509

    Cyanovirin variant-polymer conjugates

    Nektar Therapeutics AL, Corporation · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted

  5. US 7544738

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  6. US 7528202

    Poly (ethylene glycol) derivatives with proximal reactive groups

    Nektar Therapeutics AL, Corporation · Granted May 5, 2009 · Expires Apr 30, 2029

    granted

  7. US 7511094

    Water-soluble polymer alkanals

    Nektar Therapeutics AL, Corporation · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  8. US 7511095

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics AL, Corporation · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  9. US 7432331

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics AL, Corporation · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

  10. US 7432330

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics AL, Corporation · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

  11. US 7419600

    Method for purifying a branched water-soluble polymer

    Nektar Therapeutics AL, Corporation · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  12. US 7405266

    Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics AL, Corporation · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  13. US 7378469

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted May 27, 2008 · Expires May 22, 2028

    granted

  14. US 7329721

    Maleamic acid polymer derivatives and their bioconjugates

    Nektar Therapeutics AL, Corporation · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

  15. US 7316811

    Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted

  16. US 7312301

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics AL, Corporation · Granted Dec 25, 2007 · Expires Dec 20, 2027

    granted

  17. US 7265186

    Multi-arm block copolymers as drug delivery vehicles

    Nektar Therapeutics AL, Corporation · Granted Sep 4, 2007 · Expires Aug 30, 2027

    granted

  18. US 7223803

    Polyethylene (glycol) derivatives with proximal reactive groups

    Nektar Therapeutics AL, Corporation · Granted May 29, 2007 · Expires May 24, 2027

    granted

  19. US 7214366

    Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules

    Nektar Therapeutics AL, Corporation · Granted May 8, 2007 · Expires May 3, 2027

    granted

  20. US 7208145

    Polymeric reagents comprising a ketone or a related functional group

    Nektar Therapeutics AL, Corporation · Granted Apr 24, 2007 · Expires Apr 19, 2027

    granted

  21. US 7205380

    Sterically hindered poly (ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics AL, Corporation · Granted Apr 17, 2007 · Expires Apr 12, 2027

    granted

  22. US 7199223

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics AL, Corporation · Granted Apr 3, 2007 · Expires Mar 29, 2027

    granted

  23. US 7157546

    Water-soluble polymer alkanals

    Nektar Therapeutics AL, Corporation · Granted Jan 2, 2007 · Expires Dec 28, 2026

    granted

  24. US 7101932

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)

    Nektar Therapeutics AL, Corporation · Granted Sep 5, 2006 · Expires Aug 31, 2026

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.